Kisspeptin Guide
GnRH Master Regulator
Complete Kisspeptin guide: master regulator of GnRH/LH pulse, 1–3 mcg/kg dosing, testosterone and ovulation control, hypogonadism research.
Master GnRH Regulator: Testosterone, Fertility & HPG Axis Optimization (2026)
Kisspeptin is the master upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis — controlling the pulsatile release of GnRH that drives LH, FSH, testosterone, and estrogen. Discovered in 2003 as the KISS1 gene product, it represents the highest-level control point for reproductive hormone regulation in both men and women, with applications in hypogonadism, fertility, and hormonal optimization research.
What Is Kisspeptin?
Kisspeptin refers to a family of neuropeptides derived from the KISS1 gene product via proteolytic cleavage. The principal forms are Kisspeptin-54 (54 amino acids, the full-length secreted form), Kisspeptin-14, Kisspeptin-13, and Kisspeptin-10 (the minimal bioactive C-terminal decapeptide). All forms bind the GPR54 receptor (also called KISS1R) and are equipotent at the receptor level.
Kisspeptin neurons in the arcuate nucleus and anteroventral periventricular nucleus of the hypothalamus project directly to GnRH neurons. When Kisspeptin binds GPR54 on these GnRH neurons, it triggers a robust GnRH pulse — the downstream signal that drives LH and FSH release from the pituitary, and ultimately testosterone (in testes) and estradiol (in ovaries). Disruptions in Kisspeptin signaling cause hypogonadotropic hypogonadism — low testosterone/estrogen with normal or low LH/FSH.
The discovery of Kisspeptin's role in reproductive biology came from studying humans with KISS1 or KISS1R loss-of-function mutations — who all had complete hypogonadotropic hypogonadism (no puberty, no sex hormone production). This confirmed Kisspeptin as the master gate controlling the entire reproductive endocrine system — now the subject of intense clinical research for fertility treatment, sex hormone optimization, and endocrine dysfunction.
Key Actions & Applications
Testosterone Stimulation (Men)
In men with hypogonadotropic hypogonadism, pulsatile Kisspeptin administration restores GnRH pulsatility, normalizing LH and testosterone levels. A 2022 King's College London trial showed Kisspeptin-5
Fertility & Ovulation (Women)
In women with hypothalamic amenorrhea (absent periods due to low GnRH), Kisspeptin-54 infusion successfully triggered ovulation in 70% of women who failed conventional therapy in a 2015 Nature Medicin
Sexual Function & Libido
Kisspeptin has direct effects on sexual arousal and partner attraction beyond its gonadotropin-stimulating role. GPR54 receptors are expressed in limbic brain areas governing sexual motivation. A Univ
HPG Axis Desensitization Risk
Paradoxically, continuous Kisspeptin administration causes GPR54 receptor desensitization — suppressing GnRH release and lowering LH/T, similar to continuous GnRH agonist administration (as used in ch
Kisspeptin Dosing
Pulsatile dosing is critical — continuous use will suppress rather than stimulate. Use Shotlee to track dose timing and LH/testosterone lab results. All human use is experimental research off-label application.
Guide FAQs
Complete Kisspeptin guide: master regulator of GnRH/LH pulse, 1–3 mcg/kg dosing, testosterone and ovulation control, hypogonadism research.
Yes. Shotlee supports tracking Kisspeptin doses, side effects, and health metrics. It is free to use.
PubMed, ClinicalTrials.gov, and the FDA website are the most reliable sources for current Kisspeptin research and regulatory updates. Peer-reviewed journals including the New England Journal of Medicine, The Lancet, and JAMA publish the most impactful clinical trial results. This guide is updated regularly to reflect the latest available evidence. Use Shotlee to track your personal protocol outcomes alongside the published research.
Before starting Kisspeptin, establish baseline measurements including body weight, waist circumference, blood pressure, and relevant lab work with your healthcare provider. Download Shotlee and begin logging your baseline metrics at least one week before starting treatment. This pre-treatment data provides the comparison point needed to objectively evaluate your treatment response over time. Additionally, discuss potential side effects and management strategies with your prescriber so you are prepared for the initial adaptation phase.
Evidence-based lifestyle modifications that complement Kisspeptin protocols include: maintaining adequate protein intake (1.2-1.6g per kg body weight per day) to preserve lean mass, performing resistance training two to three times per week, staying well hydrated with at least eight glasses of water daily, prioritizing seven to nine hours of quality sleep, managing stress through regular physical activity or mindfulness practices, and eating smaller more frequent meals during dose titration phases. Track these lifestyle factors alongside your Kisspeptin data in Shotlee to identify which combinations drive your best results.
References
Track Your Kisspeptin Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
🚀 Use Shotlee for Free